Agios Pharmaceuticals, Inc. (AGIO)
BMV
Closed
Oct 2, 2026
Day's Range
1,222.0052 wk Range
1,222.00Overview - AGIO - Agios Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
1.27T
P/E (Trailing)
‪5.16‬
PEG Ratio
‪-0.41‬
Price / Sales (TTM)
‪741.88‬
Price / Book
‪4.11‬
EV / EBITDA
‪-159.51‬
Profitability
Gross Margin
‪93.30%‬
Profit Margin
‪88.25%‬
Operating Margin
‪-247.07%‬
Return on Assets
‪-22.24%‬
Return on Equity
‪-34.33%‬
Ownership
Shares Outstanding
59.60M
Float
50.01M
Held by Insiders
‪1.06%‬
Held by Institutions
‪112.30%‬
Price stats
Beta
‪0.60‬
50-Day Avg
‪1,222.00‬
200-Day Avg
‪1,222.00‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - AGIO - Agios Pharmaceuticals, Inc.
Peers - AGIO - Agios Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- AGIOBMVAgios Pharmaceuticals, Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt1.05TMarket Cap+10.77%52-week change36.36P/E (Trailing)‪32.26%‬Profit Margin
- ALNYBMVAlnylam Pharmaceuticals, Inc.742.50BMarket Cap-51.02%52-week change53.47P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNBMVBioNTech SE American Depositary Share413.38BMarket Cap-18.50%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- ASND1NBMVAscendis Pharma A/S291.08BMarket Cap+3.50%52-week change19.80P/E (Trailing)‪70.84%‬Profit Margin
- BMRNBMVBioMarin Pharmaceutical Inc.213.89BMarket Cap+10.22%52-week change172.39P/E (Trailing)‪2.14%‬Profit Margin
- ARWRBMVArrowhead Pharmaceuticals, Inc.64.02BMarket Cap+0.00%52-week change-45455.00P/E (Trailing)‪-47.79%‬Profit Margin
Profile Summary - AGIO - Agios Pharmaceuticals, Inc.
About
Agios Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing medicines for rare diseases through its expertise in cellular metabolism. The company’s core commercial product is PYRUKYND (mitapivat), an oral pyruvate kinase activator used in hemolytic anemia associated with pyruvate kinase…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
